Search Ontology:
ChEBI
beta-D-GlcNAc-(1->4)-MDP-Lys(L18)
- Term ID
- CHEBI:71405
- Synonyms
-
- (2R)-2-{[(4R)-4-{[(2S)-2-{[(2R)-2-{[(2R,3R,4R,5S,6R)-3-acetamido-5-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}propanoyl]amino}propanoyl]amino}-5-amino-5-oxopentanoyl]amino}-6-(octa
- GlcNAcb1-4-MDPLys
- GlcNAcbeta1-4MDPLys
- N(2)-{[4-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-N-acetylmuramyl]-L-alanyl-D-isoglutaminyl}-N(6)-stearoyl-L-lysine
- N(2)-{[4-O-(N-acetyl-beta-D-glucosaminyl)-N-acetylmuramyl]-L-alanyl-D-isoglutaminyl}-N(6)-stearoyl-L-lysine
- Definition
- A glycopeptidolipid consisting of L-lysine, to the N-2 of which is attached an N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetylmuramoyl moiety connected to the amino terminus of the dipeptide L-alanyl-D-isoglutamine, and to the N-6 of which is attached a stearoyl group.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from beta-D-GlcNAc-(1->4)-MDP-Lys(L18)
Phenotype where environments contain beta-D-GlcNAc-(1->4)-MDP-Lys(L18)
Phenotype modified by environments containing beta-D-GlcNAc-(1->4)-MDP-Lys(L18)
Human Disease Model